Z-0919-2021 Class II Terminated
FDA device recall Z-0919-2021 was initiated by Hardy Diagnostics on Dec 21, 2020 and is designated Class II. Reason for recall: Complaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited. The recall status is terminated (terminated Sep 28, 2022). Affected quantity: 820 units (82 PK10).
Recall details
- Product Type
- Devices
- Report Date
- Feb 3, 2021
- Initiation Date
- Dec 21, 2020
- Termination Date
- Sep 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 820 units (82 PK10)
Product description
Brain Heart Infusion Agar with 6 ug/ml Vancomycin Cat no: G14 Lot no: 472698 Manufactured: 2020-10-29 Expires: 2020-12-28 Container Type: 15x100mm plate, 18 ml
Reason for recall
Complaints were received reporting of Staphylococcus aureus (ATCC 29213) breakthrough when the strain should have been inhibited.
Distribution pattern
U.S.: CA, UT, MI, Puerto Rico, IN, CT, AZ, GA, MA, TN, WA O.U.S. None
Code information
Catalog Number: G14 UDI Code: 00816576020102 Lot Number: 472698
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0919-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026